A study evaluating long telomere length of ER expression in 200 breast cancer patients did not find any statistically significant difference in the prognosis between ER+ and ER- patients, but it did find that ER+ cases had longer telomere length compared to control cases (16). The gene discussed is ESR1; the disease is breast cancer.